Jay Burkhardt

Jay Burkhardt is a seasoned strategy and operations executive with a successful track record of leading high-growth public and private companies in the healthcare sector.

His specialized expertise encompasses operations, mergers & acquisitions, corporate development, strategy, financial analysis & valuation, market analysis, corporate finance, due diligence & integrations, budgeting & forecasting, and go-to-market planning.

Jay Burkhardt has a strong educational background, having studied Mergers & Acquisitions at The Wharton School, an MBA in Strategy from Thunderbird School of Global Management, an MBA in Finance from Oklahoma State University, and studied at DePauw University.

Throughout his career, Jay Burkhardt has held key leadership roles in prestigious organizations. He served as the President, Chief Operating Officer, Chief Strategy Officer, and Chief Development Officer at Probo Medical. Additionally, he has held executive positions at PhyMed Healthcare Group, The US Oncology Network, McKesson, and SemGroup Corporation.

Jay Burkhardt's extensive experience includes spearheading operations, leading mergers & acquisitions, driving corporate development initiatives, formulating strategic plans, conducting financial analysis and valuation, market analysis, and overseeing budgeting & forecasting operations. His expertise also extends to go-to-market planning and due diligence & integrations.

With a deep understanding of the healthcare industry and a proven record of achievement in strategy and operations, Jay Burkhardt is a highly respected professional known for his strategic vision and analytical acumen.